Ex JNJ employee now Vice President of Sales at Geron....

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
kmall
Posts: 398
Joined: Thu Mar 21, 2019 3:57 pm

Ex JNJ employee now Vice President of Sales at Geron....

Post by kmall » Mon Nov 07, 2022 8:56 pm

Scott Hutson - Vice President of Sales, Geron Corporation

Hired - Nov 2022

10/20/2022 - FOSTER CITY, Calif.--(BUSINESS WIRE) - Geron Corporation (Nasdaq: GERN) reported that it has granted non-statutory stock options to purchase an aggregate of 843,260 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company. Scott Hutson is one of these new hired employees.

Scott Hutson's previous employers include: JNJ, AstraZeneca, Medivation, Bristol Meyers Squibb

"Experienced Oncology Leader with progressive and diverse experience in US, Regional and National roles with a consistent track record of delivering on business results, championing collaboration and fostering organizational innovation. Led and managed large groups, sales, training & marketing teams, cross-functional, cross-regional teams and alliance partnerships. Extensive and successful experience in partnering with Marketing, Regulatory, Medical, Market Access functions and Sales Regions to optimize commercial product development & shape clinical/commercial/access strategies. Highly skilled at developing commercial teams, launching products and expanding crucial business segments within US markets. Consistent track record of success in IV Infusible, Bio-Injectable & Oral Product lines. Proven success working with Oncolytic Agents that utilize Specialty Pharmacies, Specialty Distributors, and Proprietary GPO's, that require all levels of Commercial & Access Service Support. I have a passion and dedication in the Oncology space and I have become an innovative leader with a unique ability to build out strong commercial franchises across solid tumor, hematology and immunology teams."

*Interestingly enough not only was Scott Hutson an 11yr veteran at JNJ, specializing in Oncology Sales throughout his 25+ year career, but he was also employed by Medivation prior to Aron Feingold and it's $14B acquisition by Pfizer. One of the largest in Biopharma history. Just another thing to be paying attention to. -Kmall

biopearl123
Posts: 1105
Joined: Fri Jul 20, 2018 5:13 pm

Re: Ex JNJ employee now Vice President of Sales at Geron....

Post by biopearl123 » Mon Nov 07, 2022 11:17 pm

Serious kudos to Kmall, master of the connected dot!

kmall
Posts: 398
Joined: Thu Mar 21, 2019 3:57 pm

Re: Ex JNJ employee now Vice President of Sales at Geron....

Post by kmall » Tue Nov 08, 2022 4:10 am

Bp - "I have a passion and dedication in the Oncology space and I have become an innovative leader with a unique ability to build out strong commercial franchises across solid tumor, hematology and immunology teams." - Scott Hutson - Vice President of Sales, Geron Corporation

kmall
Posts: 398
Joined: Thu Mar 21, 2019 3:57 pm

Re: Ex JNJ employee now Vice President of Sales at Geron....

Post by kmall » Tue Nov 08, 2022 8:28 am

Scott Hutson - JNJ - 1999 - 2010

Sr. Sales Director - Oncology
Johnson & Johnson
Jul 1999 - Jun 2010 11 yrs
US Commercial Oncology Team
Product Launches:
Procrit
Doxil - Ovarian Cancer, Breast Cancer
Doxil - Multiple Myeloma
Doxil & Velcade - Multiple Myeloma
Nucynta - Oncology Breakthrough Pain Management
Zytiga - Prostate Cancer


Johnson & Johnson
Centocor Ortho Biotech, Oncology (1999-2010)

Sr. Regional Business Director of Oncology – September 2004 – June 2010

Ortho Biotech Products L.P. is a leading biopharmaceutical company with over $2 billion dollars in sales that provides innovative products and services designed to help enhance the lives of individuals with cancer, chronic kidney disease, and other serious chronic illnesses

Responsible for the Centocor Ortho Biotech Oncology Division for the Western US:
Led and managed regions covering major geographies across the Western, and Central US
Responsible for Chemotherapeutic infusible (Doxil®), (Velcade®), Oral Analgesic for Pain Management (Nucynta®), Biologic Injectable (Procrit®), and IV infusible for RA (Remicade®), in all major business segments (Hospitals, Community and Academic, IDN’s, & Clinics)

Hired, Managed, coached and Developed a High Performing sales team:
7 District Mangers, 2 Strategic Account Directors
65 Hospital and Clinic Product Specialists
Dotted line management for multiple Strategic Account Managers, Reimbursement Directors and Business Solutions Directors across all business segments.

Managed Complex Critical Markets in Multiple Therapeutic areas from launch to over $500 MM in total yearly annual buy and bill sales.

*Talk about a prime candidate for the highly awaited commercial launch of Imetelstat.

HUTSON......we have liftoff !!!!! -Kmall

mistergern
Posts: 35
Joined: Sat Mar 19, 2016 3:48 pm

Re: Ex JNJ employee now Vice President of Sales at Geron....

Post by mistergern » Tue Nov 08, 2022 4:51 pm

Extremely encouraging news Kamal - mucho gracias for sharing your research!!!

kmall
Posts: 398
Joined: Thu Mar 21, 2019 3:57 pm

Re: Ex JNJ employee now Vice President of Sales at Geron....

Post by kmall » Wed Nov 09, 2022 1:09 am

Aswin Jayaraman MBA, MS - Director IT Applications, Geron Corporation

Hired - Aug 2022

8/18/2022 - FOSTER CITY, Calif.- (BUSINESS WIRE) - Geron Corporation (Nasdaq: GERN)
reported that it has granted non-statutory stock options to purchase an aggregate of 365,800 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company. Aswin Jayaraman is one of these newly hired employees.

Aswin Jayaraman's former employers include: Nektar Therapeutics, Exact Sciences, Atari, IBM, Fidelity Investments, Cornerstone Research, Global IT Operations, Sopra Steria, Tata Consulting Services

"My vision is to empower multinational organizations through my solution-driven management and strong leadership skills. I strongly believe that focusing on shaping cohesive, high-functioning teams is the key to achieving results that we can all be proud of, irrespective of the specific domain or product being built." - Aswin Jayaraman

*Geron continues building on supportive positions to strengthen it's Clinical Operations. Growing up during the Golden Age of video games, I think it's pretty cool that a former Atari employee now calls Geron home. Space Invaders anyone? -Kmall

biopearl123
Posts: 1105
Joined: Fri Jul 20, 2018 5:13 pm

Re: Ex JNJ employee now Vice President of Sales at Geron....

Post by biopearl123 » Wed Nov 09, 2022 3:32 am

Kmall, you and I always said even years ago that when Geron finally hired their sales force, we would take special note and that would mean that they have the goods. Looks like they do. Its going to get interesting. Best Regards, bp

kmall
Posts: 398
Joined: Thu Mar 21, 2019 3:57 pm

Re: Ex JNJ employee now Vice President of Sales at Geron....

Post by kmall » Wed Nov 09, 2022 11:48 am

Bp - While there have been many sales related positions added in the last year or so; Nishan Sengupta - VP, Market-Access, Pricing, Evidence Strategy and Denise Meyer - VP Medical Affairs for example; Mr. Hutson is the first direct "Point of Sales" employee to be unveiled so far. It's a pretty big deal for those of us who have been following the progression of Geron since Sept 2018 and a much bigger deal for patients around the globe who will benefit from Imetelstat once approved. Let's hope that milestone achievements set forth by the company fall in line with expectations and hopefully this time next year they have at least one Regulatory Agency approval under their belt. -Kmall

Known current Geron Employees as of 11/9/2022 and their initial hiring dates –
* Former Janssen employee
+ Part-time or Consultant

Management:
1 - CEO – Dr. John A. Scarlett, MD - 2011
2 - CFO – Olivia K. Bloom - 1994
3 - CAO – Melissa A. Kelly Behrs – 1998
4. – CBO – Edward Koval - 2021
5 - COO – Andrew J. Grethlein - 2012
6 - CCO* – Anil Kapur - 2019
7 - CMO* – Faye Feller, MD - 2019
8 - CLO – Stephen N. Rosenfield - 2011

Clinical – Operations, Science, Development:
Faye Feller*(7), MD – CMO – 2019
9 - Laurie Sherman* – VP Clinical Operations – 2019
10 - Souria Dougherty* - Ex Director Clinical Science - 2019
11 - Tymara Berry – Ex Director Clinical Development - 2020
12 - Dr. Vivian Rodolf - Medical Director - 2022
13 - Sheetal Shah – Sr Director – 2020
14 - Denise Redding – Director - 2021
15 - Jeff Ryel – Director Clinical Operations - 2020
16 - Brandie Jonas – Sr Director, Clinical Program Management – 2019
17 - F Matthew Bakthasekaran - Sr Manger, Clinical Program Management - 2022
18 - Judy Ho - Sr Manager - 2022
19 - Natasha M - Associate Director, Clinical Research - 2021
20 - Manoj Jivani - Director Clinical Operations - 2022
21 - Kate Turner - Associate Director Clinical Operations - 2022
22 - Jennifer Riggs* - Associate Director Clinical Science - 2022
23 – Carolina Jacobs – Sr Project Manager - 2012
24 - Daria Zielinska – Sr Scientist – 2001
25 - Ron Pruzan – Principal Scientist – 2010
26 – Yelena Polonskaya – Sr Research Associate - 2001
27 - Barbara Mandelkow (Germany) Lab Assistant - 2017
28 - Janet Ahern(+) - Clinical Research Consultant - 2022
29 - Dr. Aleksandra Rizo*(+) - Sr. Medical and Regulatory Advisor - 2019
(currently employed at Vividion and Geron)
30 - Mebratu Gebreyesus(+) - Sr Development Associate - 2010
(currently employed at Bayer, Celltheon and Geron)
31 - Kerry Mundt(+) – CT Assistant – 2010
(currently employed by Pharmacyclics/Abbvie and Geron)

Pharmacovigilance and Drug Safety/Information:
32 - Patti N. – Ex Director Drug Safety – 2020
33 - Annat Ikin - Director Medical Writing – 2021

Business Development:
Melissa A. Kelly Behrs (3) – Chief Alliance Officer – 2014
Edward Koval (4) – CBO - 2021
Anil Kapur* (6) - COO - 2019
34 - Jason Grossman - Ex Director, Commercial Operations - 2022
35 - Nishan Sengupta - VP, Market-Access, Pricing, Evidence Strategy - 2021
36 - Scott Hutson - VP Sales - 2022
37 - Denise Meyer – VP Medical Affairs – 2021
38 - Christopher Cornell - Sr. Field Medical Liaison - 2022
39 - Helen Lee – Sr. Reporting Analyst - 2012
40 - Anthony Kuczynski – Analyst - 2019
41 - Aron Feingold - VP Investor Relations & Corporate Communication - 2022

Finance:
Olivia K. Bloom (2) – CFO – 1994
42 - Karen Boyce – VP -2008
43 - Andrew Good – Ex Director – 2006
44 - Gilian Fong – Director – 2021
45 – Iasko Cable – Sr. Clinical Trial Accountant – 2019
46 – Dave Clark – CPA, Corporate Controller - 2022
47 - Katherine Harmon, CPA, Assistant Controller - 2022

Data Management:
48 - Ben Thorp - Head of Clinical Data Management - 2022
49 - Rana F.* – Director, Statistical Programming - 2020
50 - Sridevi Sridhar, CCDM – Associate Director – 2021
51 - Aswin Jayaraman - Director, IT Applications - 2022

Manufacturing:
52 - Patrick Murphy – VP Manufacturing – 2019
53 - Eric Mueller – Director – 2019
54 - Leslie C. – CMC Director - 2021
55 - Bharat Baral* – CMC Manager – 2021 & 2011
56 - William Garzon-Rodriguez* - Associate Director Drug Product Manufacturing – 2021
57 - Tim Tickner – Director, Supply Chain Management – 2022

Regulatory:
58 - Sharon McBain* - VP Global - 2019
59 - Shirin Mirshamsi* – Director EU – 2019
60 - Ilesh Sanathra* - Director Global – 2020
61 - Nick Lyon – Director – 2020
62 – Ronan Balicanta* Senior Manager, Submissions - 2022
63 - Tarin Araujo - Senior Manager US - 2022

Biostatistics:
64 - Ying Wan* – VP - 2019
65 - Libo Sun* – Director - 2019

Quality Assurance and Quality Control:
66 - Denise Grippo – VP Quality and Compliance – 2019
67 - Samantha Taylor – QA Manager, Document Control – 2007
68 - Joe Denton – Director – 2019
69 - Damanjit Singh – Sr Manager – 2018
70 - Willie Mobley – Materials/Document Specialist - 2007
71 - Leah Wood – Manager – 2021
72 - Murugappa Vedachalam (+) – QA/QC/CMC Consultant - 2019

Legal and Intellectual Property:
Stephen L. Rosenfield (8) – CLO – 2011
73 - Pamela Smith – Associate General Counsel - 1999
74 - Christopher Johnson – Director - 2019
75 - Laura Reederson – Director - 2020
76 - Leslie Mooi – VP IP – 2007
77 - Abby B. – Sr Patent Paralegal - 2014
78 - Cheryl Northern – Sr. Contracts Manager – 2007
79 – Brittney Hernandez – Contracts Manager – 2021

Facilities Operations and Information Technology:
80 - Michael Yamada – VP -2007
81 - Jyoti Shetty – Sr Director IT – 2021
82 - John Albert - Director Information Technology Infrastructure - 2022
83 - Tim W - Associate Director, IT Business Systems - 2022
84 - Miguel Hundelt – Systems Administrator – 2018
85 – Julian Cornejo - Systems Administrator - 2021
86 - Briana Martinez – Ex Assistant - 2006
87 - Julia Mensing – Ex Assistant – 2011
88 - Stacie W. – Ex Assistant - 2020
89 - Mia Pham – Office Manager - 2020

Human Resources:
90 - Shannon Odam – HR Executive -2019
91 - Stephanie Dellari – Director - 2004
92 - Susan Finan – Employee Benefits – 2021
93 - Marisa Cerniglia - Manager, People Operations – 2021
94 – Jennifer Allen - Associate Director, Talent Acquisition – 2022
95 – Fiona McAuliffe – Talent Acquisition Associate - 2022

**This latest "known" Geron employee roster reflects the most recent additions of:

36 - Scott Hutson - VP Sales
51 - Aswin Jayaraman - Director, IT Applications

As of Feb 2022 - Karie Arnold – Director Clinical Operations –2021 is no longer an employee at Geron. -Kmall

Post Reply